Association between social background and implementation of postoperative adjuvant chemotherapy for older patients undergoing curative resection of colorectal cancers, sub-analysis of the HiSCO-04 study-Reference-Cited by-同舟云学术

Association between social background and implementation of postoperative adjuvant chemotherapy for older patients undergoing curative resection of colorectal cancers, sub-analysis of the HiSCO-04 study

Published:2023-12-28 Issue:1 Volume:39 Page:
ISSN:1432-1262
Container-title:International Journal of Colorectal Disease
language:en
Short-container-title:Int J Colorectal Dis

Author:

Bekki Tomoaki^ORCID,Shimomura Manabu,Saito Yasufumi,Nakahara Masahiro,Adachi Tomohiro,Ikeda Satoshi,Shimizu Yosuke,Kochi Masatoshi,Ishizaki Yasuyo,Yoshimitsu Masanori,Takakura Yuji,Shimizu Wataru,Sumitani Daisuke,Kodama Shinya,Fujimori Masahiko,Oheda Mamoru,Kobayashi Hironori,Akabane Shintaro,Yano Takuya,Ohdan Hideki^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

https://link.springer.com/content/pdf/10.1007/s00384-023-04583-7.pdf

Reference26 articles.

1. Smith BD, Smith GL, Hurria A et al (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. Am J Clin Oncol 27:2758–2765

2. Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249

3. Sargent DJ, Goldberg RM, Jacobson SD et al (2001) A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345:1091–1097

4. Yothers G, O’Connell MJ, Allegra CJ et al (2011) Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses. Am J Clin Oncol 29:3768–3774

5. Tournigand C, André T, Bonnetain F et al (2012) Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the multicenter international study of oxaliplatin, fluorouracil, and leucovorin in the adjuvant treatment of colon cancer trial. Am J Clin Oncol 30:3353–3360